Processes for the synthesis of oligomers using phosphoramidite compositions
AssigneeIsis Pharmaceuticals, Inc.
InventorsVasulinga T. Ravikumar, Daniel C. Capaldi, Douglas L. Cole
Life of this patent
Estimating the term…
Abstract
Synthetic processes are provided wherein oligomers are prepared using phosphoramidite compositions. Oligomers having phosphodiester, phosphorothioate, phosphorodithioate covalent linkages are prepared that can include other covalent linkages. Also provided are compositions useful in such processes.
Claims54
A method of preparing an oligomer having at least one moiety of formula:
- wherein:
- each X1 and X2 is, independently, O or S;
- Bx is a protected or unpprotected heterocyclic base moiety;
- and
- each R1 is, independently, H, a protected hydroxyl group, a sugar substituent group or a protected sugar substituent group;
- comprising the steps of:
- providing a compound of the formula:
- wherein:
- T1 is a hydroxyl protecting group;
- and
- T2 is a covalent attachment to a solid support or a solid support bound nucleoside, nucleotide, oligonucleoside or oligonucleotide;
- removing the T1 group to form said compound having a 5′-hydroxyl group;
- and
- treating said compound having a 5′-hydroxyl group with a phosphoramidite composition to form an extended compound, said phosphoramidite composition comprising a phosphoramidite compound of the formula:
- wherein:
- T3 is a protected hydroxyl group, a nucleoside, a nucleotide, an oligonucleoside or an oligonucleotide;
- R0 is a phosphorus protecting group;
- and
- each L1 and L2 is, independently, C1-4 alkyl;
- or L1 and L2 are joined together to form a 4 to 7-membered heterocyclic ring system including the nitrogen atom to which L1 and L2 are attached, wherein said ring system optionally includes at least one additional heteroatom selected from O, N and S;
- said phosphoramidite composition Her comprising at least about 2% by weight of impurities comprising at least one 3′-hydroxy nucleoside, a pill species different from said phosphoramidite compound where covalent attachment of groups to the PIII phosphorus of said PIII species is through oxygen or sulfur, or a PV species where covalent attachment of groups to the PV species is through oxygen, sulfur or nitrogen.
A method of linking a nucleotide to a further nucleotide, nucleoside, oligonucleoside or oligonucleotide having a 5′-hydroxyl group thereon comprising treating said further nucleotide, nucleoside, oligonucleoside or oligonucleotide having a 5′-hydroxyl group with a phosphoramidite composition to form an extended compound, said phosphoramidite composition comprising a phosphoramidite compound of the formula:
- wherein:
- T3 is a protected hydroxyl group, a nucleoside, a nucleotide, an oligonucleoside or an oligonucleotide;
- Bx is a protected or unprotected heterocyclic base moiety;
- each R1 is, independently, H, a protected hydroxyl group, a sugar substituent group or a protected sugar substituent group;
- R0 is a phosphorus protecting group;
- and
- each L1 and L2 is, independently, C1-6 alkyl;
- or L1 and L2 are joined together to form a 4- to 7-membered heterocyclic ring system including the nitrogen atom to which L1 and L2 are attached, wherein said ring system optionally includes at least one additional heteroatom selected from O, N and S;
- said phosphoramidite composition further comprising at least about 2% by weight of impurities comprising at least one 3′-hydroxy nucleoside, a PIII species different from said phosphoramidite compound where covalent attachment of groups to the PIII phosphorus of said PIII species is through oxygen or sulfur, or a PV species where covalent attachment of groups to the PV species is by oxygen, sulfur or nitrogen.
A method of preparing an oligomer having at least one moiety of formula:
- wherein:
- each X1 and X2 is, independently O or S;
- Bx is a protected or unprotected heterocyclic base moiety;
- and
- each R1 is, independently, H, a protected hydroxyl group, a sugar substituent group or a protected sugar substituent group;
- comprising the steps of:
- providing a compound of the formula:
- wherein:
- T1 is a hydroxyl protecting group;
- and
- T2 is a covalent attachment to a solid support or a solid support bound nucleoside, nucleotide, oligonucleoside or oligonucleotide;
- removing the T1 group to form said compound having a 5′-hydroxyl group;
- and
- treating said compound having a 5′-hydroxyl group with a phosphoramidite composition to form an extended compound, said phosphoramidite composition comprising a phosphoramidite compound of the formula:
- wherein:
- T3 is a protected hydroxyl group, a nucleoside, a nucleotide, an oligonucleoside or an oligonucleotide;
- R0 is a phosphorus protecting group;
- and
- each L1 and L2 is, independently, C1-6 alkyl;
- or L1 and L2 are joined together to form a 4 to 7-membered heterocyclic ring system including the nitrogen atom to which L1 and L2 are attached, wherein said ring system optionally includes at least one additional heteroatom selected from O, N and S;
- said phosphoramidite composition further comprising at least about 1% by weight of impurities having one of the following formulas:
- wherein:
- each X2 is, independently, O or S;
- each J is CH2CH2CN, diphenylsilylethyl, δ-cyanobutenyl, cyano p-xylyl (CPX), methyl-N-trifluoroacetyl ethyl (META) or acetoxy phenoxy ethyl (APOE);
- each T4 is, independently, a hydroxyl group or a protected hydroxyl group;
- each R0 is a phosphorus protecting group;
- each L1 and L2 is, independently, C1-6 alkyl;
- or L1 and L2 are joined together with the nitrogen atom to which they are attached to form a 4- to 7-membered heterocyclic ring system, wherein said ring system optionally includes at least one additional heteroatom selected from O, N and S;
- each Bx is a protected or unprotected heterocyclic base moiety;
- and
- each R1 is, independently, H, a protected hydroxyl group, a sugar substituent group or a protected sugar substituent group.
A method of preparing an oligomer having at least one moiety of formula:
- wherein:
- each X1 and X2 is, independently, O or S;
- Bx is a protected or unprotected heterocyclic base moiety;
- and
- each R1 is, independently, H, a protected hydroxyl group, a sugar substituent group or a protected sugar substituent group, said method comprising the steps of:
- (a) providing a phosphoramidite composition, said phosphoramidite composition comprising an amidite of formula:
- wherein:
- T3 is a protected hydroxyl group, a nucleoside, a nucleotide, an oligonucleoside or an oligonucleotide;
- R0 is a phosphorus protecting group;
- and
- each L1 and L2 is, independently, C1-6 alkyl;
- or L1 and L2 are joined together to form a 4 to 7-membered heterocyclic ring system including the nitrogen atom to which L1 and L2 are attached, wherein said ring system optionally includes at least one additional heteroatom selected from O, N and S,
- said phosphoramidite composition further comprising at least about 1% by weight of inert impurities, said impurities comprising at least one 3′-hydroxy nucleoside, a PIII phosphorus species different from said phosphoramidite compound where covalent attachment of groups to the PIII phosphorus of said PIII species is through oxygen or sulfur, or a PV species where covalent attachment of groups to the PV species is through oxygen, sulfur or nitrogen;
- (b) assaying the phosphoramidite composition, whereby said at least about 1% by weight of inert impurities are detected;
- (c) providing a compound of formula:
- wherein
- T1 is a hydroxyl protecting group;
- and
- T2 is a covalent attachment to a solid support or a solid support bound nucleoside, nucleotide, oligonucleoside or oligonucleotide;
- and
- (d) reacting the compound of step (c) with the phosphoramidite composition of step (b) to form an extended compound.
Dependencies are inferred from the claim text.